BioCentury
ARTICLE | Company News

Epimmune, Anosys deal

February 17, 2003 8:00 AM UTC

EPMN and cancer vaccine company Anosys said they will merge in an all stock transaction. The combined company will bring together EPMN's epitope technology and Anosys' exosome delivery technology and ...